Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAL201 in Advanced Prostate Cancer and Solid Tumours
NCT02280317Phase 2Completed
- Sponsor
- ValiRx plc
- Start
- Oct 2014
- Primary completion
- Jan 2020
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of VAL201 in prostate cancer (PCa), solid tumor, sponsored by ValiRx plc. Started Oct 2014; status: completed.
02
Drugs
VAL201
03
Conditions
prostate cancer (PCa)solid tumor
Beyond the preview
Go deeper on NCT02280317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280317.